Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
4
×
national blog main
boston blog main
national
national top stories
new york blog main
new york top stories
startups
abbvie
astrazeneca
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
covid-19
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
unity biotechnology
What
ceo
4
×
acquisitions
announced
bio
daniel
drug
gilead
medicines
o’day
research
roundup
sciences
aims
alex
backed
biggest
build
buy
cause
collaboration
collabs
company’s
covid
deal
debut
discovery
drugs
dyne’s
entered
epilepsy
genes
genetic
gilead’s
help
insilico
introduce
ipo
links
marcio
medicine
Language
unset
4
×
Current search:
biotech
×
ceo
×
unset
×
" life sciences "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery